Evidence map›Paper›PMID 37772077›Full record

ReviewFrontiers in endocrinology2023

Lawrence M Nelson, Hillary Spencer, Karima Hijane, Payom Thinuan, Chaninan W Nelson, Amanda J Vincent, Catherine M Gordon, Tony M Plant, Pouneh K Fazeli

Open access · goldAbstract readReviewCase Reports
In one paragraph

Review in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Lawrence M NelsonDigital Women's Health Initiative, Mary Elizabeth Conover Foundation, Tysons, VA, United States.
Hillary SpencerDigital Women's Health Initiative, Mary Elizabeth Conover Foundation, Tysons, VA, United States.
Karima HijaneDigital Women's Health Initiative, Mary Elizabeth Conover Foundation, Tysons, VA, United States.
Payom ThinuanFaculty of Nursing, Boromarajonani College of Nursing Nakhon, Lampang, Thailand.
Chaninan W NelsonDigital Women's Health Initiative, Mary Elizabeth Conover Foundation, Tysons, VA, United States.
Amanda J VincentMonash Centre for Health Research and Implementation (MCHRI), Monash University, Clayton, VIC, Australia.
Catherine M GordonEndocrinology and Metabolism, Baylor College of Medicine, Houston, TX, United States.
Tony M PlantEndocrinology and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Pouneh K FazeliEndocrinology and Metabolism, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Women's Health Initiative · USUniversity of Pittsburgh · USBaylor College of Medicine · USBoromarajonani College of Nursing · THMonash University · AU

Funding

Transdermal estrogen for the treatment of bone loss in women with anorexia nervosaR01HD099139 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FAZELI, POUNEH KHADEJEH · 2019 to 2023
$1.7M
NICHD NIH HHS R01 HD099139
6 · The paper itself

Abstract

There is a need to close the gap between knowledge and action in health care. Effective care requires a convenient and reliable distribution process. As global internet and mobile communication increase capacity, innovative approaches to digital health education platforms and care delivery are feasible. We report the case of a young African woman who developed acute secondary amenorrhea at age 18. Subsequently, she experienced a 10-year delay in the diagnosis of the underlying cause. A global digital medical hub focused on women's health and secondary amenorrhea could reduce the chance of such mismanagement. Such a hub would establish more efficient information integration and exchange processes to better serve patients, family caregivers, health care providers, and investigators. Here, we show proof of concept for a global digital medical hub for women's health. First, we describe the physiological control systems that govern the normal menstrual cycle, and review the pathophysiology and management of secondary amenorrhea. The symptom may lead to broad and profound health implications for the patient and extended family members. In specific situations, there may be significant morbidity related to estradiol deficiency: (1) reduced bone mineral density, 2) cardiovascular disease, and 3) cognitive decline. Using primary ovarian insufficiency (POI) as the paradigm condition, the Mary Elizabeth Conover Foundation has been able to address the specific global educational needs of these women. The Foundation did this by creating a professionally managed Facebook group specifically for these women. POI most commonly presents with secondary amenorrhea. Here we demonstrate the feasibility of conducting a natural history study on secondary amenorrhea with international reach to be coordinated by a global digital medical hub. Such an approach takes full advantage of internet and mobile device communication systems. We refer to this global digital women's health initiative as

Indexed as

AmenorrheaWomen's HealthAdolescentEstradiolFemaleHumansMenstrual CycleEstradiolamenorrhea - diagnosisdigital medicalestradiol (17ß-estradiol)hormone replacement therapyphysiology reproductionpolicy & institutional actionspreventative medicinetherapy

Identifiers

PMID37772077
PMCPMC10523024
OpenAlexW4386695842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.